Animal Testing for Vaccines
Implementing Replacement, Reduction and Refinement:
Challenges and Priorities
IABS and Vac2Vac are honoured to be organizing a Global Congress that will focus on replacement of in vivo testing of vaccines by in vitro methods with utilization of new and improved technologies. Progresses made with analytical tools and their applications have contributed to development of fast, precise and highly reliable in vitro tests that will allow batch to batch release of vaccines by consistency approach. Recent case studies on specific vaccines will be reviewed, and ongoing as well as future studies on other vaccines will be discussed. A particular emphasis will be placed on global coordination in areas of manufacturing and testing practices, and regulatory acceptance, with the goal of reducing time to market and increasing global access to vaccines. Participation from all of these areas of vaccine development, especially from LMICs and GAVI countries, is strongly encouraged. Bangkok has been selected as the site for this Congress because of its location amid countries with emerging vaccine producers and growing needs for vaccines.
We are honoured to have pledges of support from global foundations and partners from emerging economies.